Suchergebnisse - "YO603Y8113"

PubPharm (599)

1

Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Meng, S. | Gao, Y. | Qiang, G. | +5

2

FMO-guided design of darunavir analogs as HIV-1 protease inhibitors

enthalten in: Scientific reports | 2024

von Chuntakaruk, H. | Hengphasatporn, K. | Shigeta, Y. | +5

3

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

4

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

5

Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19

enthalten in: Combinatorial chemistry & high throughput screening | 2021

von Talluri, S.

6

Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors : Structure-based design, synthesis, biological evaluation and docking study

enthalten in: PloS one | 2020

von Zhou, H. | Zhu, M. | Ma, L. | +6

7

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

8

Exploring molecular mechanism of allosteric inhibitor to relieve drug resistance of multiple mutations in HIV-1 protease by enhanced conformational sampling

enthalten in: Proteins | 2018

von Chen, J. | Peng, C. | Wang, J. | +1

9

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Delino, N. | Aoki, M. | Hayashi, H. | +7

10

Analysis of the HIV-2 protease's adaptation to various ligands : characterization of backbone asymmetry using a structural alphabet

enthalten in: Scientific reports | 2018

von Triki, D. | Cano Contreras, M. | Flatters, D. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[60]